SUNNYVALE, Calif., September 13, 2016 — Viewics, the dedicated provider of advanced analytics that gives healthcare organizations unprecedented access to disparate data sources, today announced the launch of Viewics Diabetes Management (vCAT)™, a free solution that enables clinical laboratories to provide value-based healthcare organizations with analytics that directly support management of diabetic populations. This is the first product launched in Viewics’ new Catapult™ product line, which aims to deliver analytics capabilities to health systems without investment or IT involvement.
In the shifting value-based marketplace, healthcare organizations need to be able to effectively analyze their performance on diabetes quality measures, but often lack the tools to do so. At the same time, laboratories are challenged to increase and optimize their offerings to demonstrate their value to healthcare executives. Viewics Diabetes Management (vCAT) creates an opportunity for laboratories to provide clinicians and health executives with actionable analytics as a value-added service.
“It is critical for laboratories to provide evidence of economic contribution in accountable care and other alternative payment model settings,” said Dr. Eleanor Herriman, Chief Medical Informatics Officer at Viewics. “Offering these analytics elevates the value laboratories provide, setting them apart from their competitors in the market.”
Viewics Diabetes Management (vCAT) includes dashboards to help health systems improve their diabetes care by identifying opportunities for performance intervention.
Viewics Diabetes Management (vCAT) includes analytics dashboards to track the percentage of a provider’s population that has received key laboratory tests, and whether the results of those tests are within targets established by quality measures. This is critical information for meeting Medicare quality measures that determine reimbursement and performance scores.
Viewics’ comprehensive suite of analytics gives laboratories the power to deliver invaluable diabetes and chronic kidney disease (CKD) analytics to accountable care organizations (ACOs) and health systems. Tools such as Viewics Diabetes Management (vCAT) have been proven to drive provider performance improvement in diabetes population health management.
“We recognize that organizations are all at different stages of the journey toward a data-driven culture,” said Tim Kuruvilla, co-founder and Chief Commercial Officer at Viewics. “Our new Catapult program helps jumpstart the process of implementing analytics with no risk, and without relying on overburdened IT departments.”
Viewics provides unprecedented access to disparate healthcare data to surface actionable intelligence and empower data-driven decision-making. Through expertise and focus on healthcare analytics, Viewics delivers proprietary, best-in-class technology for data extraction, cleansing, and transformation to quickly unlock insights that deliver invaluable clinical and financial impact, while reducing burden on IT.
The HIPAA-compliant solution puts the transformational power of analytics into the hands of healthcare professionals in clinical, financial, executive, and IT roles. The solution is customized and supported to enable organizations to move with agility, make decisions based on accurate data, see insights at-a-glance, and deliver great impact.